Patient Preferences for Adjuvant Treatment in Muscle-Invasive Urothelial Carcinoma: A Multi-Country Discrete Choice Experiment.

Kristen King-ConcialdiKathleen BeusterienSteven S Senglaub Oliver Will Dena H JaffeMiraj Y PatelMichael R Harrison

Published in: Patient preference and adherence (2023)

Patients with muscle-invasive urothelial carcinoma who underwent radical resection preferred adjuvant treatment over no treatment regardless of side effects. Patients prioritized overall survival improvements followed by a reduced side effect profile.

Keyphrases

end stage renal disease
early stage
skeletal muscle
chronic kidney disease
ejection fraction
newly diagnosed
case report
peritoneal dialysis
patient reported